High-Sensitivity CRP: Systemic Inflammation and Glaucoma Neurodegeneration
For example, activated microglia are known to release TNF-α and IL-1ÎČ which can trigger retinal ganglion cell death. Studies in animal models and...
DjupgÄende forskning och expertguider för att upprÀtthÄlla din synhÀlsa.
For example, activated microglia are known to release TNF-α and IL-1ÎČ which can trigger retinal ganglion cell death. Studies in animal models and...
Starta ditt gratis synfÀltstest pÄ mindre Àn 5 minuter.
Starta test nuCardiometabolic risk describes the chance that a person will develop heart disease, stroke, or type 2 diabetes because of a cluster of related health factors. These include high blood pressure, abnormal cholesterol levels, high blood sugar or insulin resistance, excess abdominal fat, and elevated triglycerides. The concept emphasizes that these problems often occur together and multiply the overall risk more than any single issue would on its own. People with higher cardiometabolic risk are more likely to experience heart attacks, strokes, and diabetes-related complications over time. Clinicians assess this risk using measurements like blood pressure, blood tests, waist size, and sometimes combined risk scores that put several pieces of information together. Many drivers of cardiometabolic risk are linked to lifestyleâpoor diet, physical inactivity, smoking, and excess weightâso prevention and early management focus heavily on behavior changes. Treatments can include lifestyle programs, medicines to control blood pressure and cholesterol, and drugs for blood sugar when needed. Lowering cardiometabolic risk improves both short-term health and long-term outcomes, and public health efforts aim to reduce it across whole populations. Regular screening and early action are important because many people feel fine in the early stages, yet timely steps can prevent serious problems later.